MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games

sobriety policy

Search medical newsFind research, conditions and clinical updates
  • Home
  • sobriety policy
重新审视强制戒酒期:对酒精相关肝病肝移植结局的影响
Posted inClinical Updates Gastroenterology Internal Medicine

Reevaluating Mandatory Sobriety Periods: Impact on Liver Transplant Outcomes in Alcohol-Associated Liver Disease

Posted by By MedXY 11/20/2026
Removing the 6-month sobriety requirement before liver transplantation improves access and long-term survival for patients with alcohol-associated liver disease without compromising outcomes in non-alcoholic etiologies.
Read More

Take a game break

Explore a few games from MedXY.

Explore all games
  • AI-Assisted Riemann Hypothesis Claim Sparks Debate Over Verification—and Signals a Broader “AI Moment” for Science
  • 1.5 kg Emerges as a Key Risk Threshold in Transcatheter PDA Closure for Small Infants
  • Harnessing Digital Parenting to Reduce Childhood Sexual Violence and Maltreatment: Evidence from a Large-scale Tanzanian Trial
  • Integrating Children into the Primary Care Investment Conversation: A Critical Imperative
  • Targeting FcRn to Combat Systemic Sclerosis: Promising Preclinical Advances with Efgartigimod
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk case report chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation machine learning MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top